UMC | UMEDIC GROUP BERHAD

8 8
0.675 (0.0%)

T-O (am): 0.680 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

UMC | UMEDIC GROUP BERHAD


iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
11 Mar 24 Q2 Jan 24 2 31 Jul 24 13.48 3.95 2.48 18.4% 0.00 0.66 7.2% 7.7% 31.3% 14.8%
04 Dec 23 Q1 Oct 23 1 31 Jul 24 14.52 2.63 1.89 13.0% 0.00 0.51 20.9% 28.4% 44.0% 5.6%
12 Sep 23 Q4 Jul 23 4 31 Jul 23 12.02 4.50 3.37 28.1% 0.00 0.90 25.4% 62.1% 65.7% 493.5%
07 Jun 23 Q3 Apr 23 3 31 Jul 23 9.59 2.46 2.04 21.2% 0.00 0.54 23.4% 48.1% 30.0% 58.2%
06 Mar 23 Q2 Jan 23 2 31 Jul 23 12.52 3.73 2.91 23.2% 0.00 0.78 10.6% 45.4%
02 Dec 22 Q1 Oct 22 1 31 Jul 23 11.31 2.25 2.00 17.7% 0.00 0.54 52.7% 252.3%
13 Sep 22 Q4 Jul 22 4 31 Jul 22 7.41 0.30 0.57 7.7% 0.00 0.15 14.5% 55.8%
22 Jul 22 Q3 Apr 22 3 31 Jul 22 6.47 1.47 1.29 19.9% 0.00 0.34

Historical Dividends

Financial Ratios

EPS 2.61 sen
Trailing PE (Sector Median: 28.4) 25.8
PEG 1.56
Altman Z 1.7
Beaver 0.288
Current Ratio 9.86
Debt-Equity (DE) Ratio 0.14
FCF Yield 0.57 %
Revenue QoQ -7.19 %
Revenue YoY 7.68%
Profit QoQ 31.29 %
Profit YoY -14.75 %
Profit Margin (Sector Median: -4.6) 19.71 %
ROE (ROIC: 14.35) 14.51 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 28.4)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: -4.6)
ROE (ROIC: 13.63)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 2 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.18
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 2.29
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0
Expected Revenue (M) 0
Expected Growth (%) 0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Summary


Market Cap: 252 M.

Number of Shares: 373 M.

Adjusted Float: 37.8%.

Stock highly correlated with

GENETEC (65%)

LYC (65%)

CIHLDG (64%)

KRONO (62%)

UMediC Group Berhad is an investment holding company. Through its subsidiaries, the Group is principally involved in the marketing and distribution of various branded medical devices and consumables. It is also engaged in developing, manufacturing, and marketing its medical consumables. The Group is an authorised distributor of multiple established international medical device companies including Philips, Mindray, GE, and Merit. The Group distributes its products to its customers comprising public and private hospitals, other healthcare service providers as well as non-medical business entities. The company was incorporated in 2002 and is headquartered in Pulau Pinang, Malaysia.

Sectors: Healthcare, Health Care Equipment & Services

Code: 0256

Website: https://www.umedichealthcare.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 29-Sep-2023

Shareholder % Value (M)
Umedic Capital Sdn Bhd 51.44% 129.83
Dato' Ng Chai Eng 5.46% 13.78
Lim Taw Seong 5.11% 12.89
Lau Chee Kheong 4.75% 11.99
Kong Yoen Hoo 2.39% 6.03
Lim Wei Yuen 1.87% 4.72
Lim Suat Gim 1.63% 4.11
Tay Moy Koh 0.72% 1.82
PB Islamic SmallCap Fund 0.59% 1.49
CIMB Bank Berhad 0.58% 1.46
Pmb Shariah Equity Fund 0.54% 1.36
Maybank Malaysia Smallcap Fund 0.48% 1.21
Ng Sze Ling 0.44% 1.11
Fortress Global Growth Fund 0.41% 1.03
United Malaysia Fund 0.4% 1.01
J.P. Morgan Securities plc 0.37% 0.93
Pb Growth Sequel Fund 0.35% 0.88
Tan Ah Nyah 0.3% 0.76
Phillip Master Equity Growth Fund 0.27% 0.68
Tokio Marine Life Insurance Malaysia Berhad 0.27% 0.68
Phillip Pearl Fund 0.26% 0.66
Lim Chin Hon 0.23% 0.58
Quah Zheng Wei 0.23% 0.58
Tan Tio Cheng @ Tan Chow Cheng 0.21% 0.53
Lim Sin Ching 0.21% 0.53
Public E-Islamic Flexi Allocation Fund 0.21% 0.53
Pan Kuan Yen 0.2% 0.5
Ling Siew Luan 0.18% 0.45
Phillip Capital Management Sdn Bhd 0.17% 0.43
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.